Form 4: VolitionRx GC Nicholas Plummer Receives Stock Award in Lieu of Cash Compensation

Nicholas Plummer, GC of VolitionRx, received 10,249 restricted stock units (RSUs) on June 1, 2024, in lieu of cash compensation.

Summary

• On June 1, 2024, Nicholas Plummer, General Counsel of VolitionRx, was granted 10,249 restricted stock units (RSUs) under the company's 2015 Stock Incentive Plan.
• The RSUs were awarded in place of cash compensation.
• The RSUs vest in three installments: 3,417 units on June 1, 2024, 3,416 units on July 1, 2024, and 3,416 units on August 1, 2024.
• The RSUs are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date.
• Upon vesting and settlement, Plummer will receive common stock equal to the number of vested RSUs.
• Following the transaction, Plummer beneficially owns 133,968 shares of common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment. This is a routine disclosure of executive compensation. It's neither particularly positive nor negative.

Positives

• The award of RSUs aligns Plummer's interests with those of the shareholders.
• Using RSUs instead of cash may preserve the company's cash reserves.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Stock awards are a common form of executive compensation in the biotechnology industry, often used to align management's interests with those of shareholders and conserve cash.

Comparison to Industry Standards

• Stock-based compensation is a standard practice among publicly traded companies, particularly in the biotech sector.
• Companies like Exact Sciences and Guardant Health also utilize stock options and RSUs as part of their executive compensation packages.
• The vesting schedule of the RSUs (three installments followed by a final vesting date) is fairly typical.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive sign of aligning management interests with company performance.
• Employees may see this as a standard compensation practice.

Key Dates